14 March 2022 - Newsletter

Successful exit: SHS puts c-LEcta in good hands

The Leipzig-based enzyme producer c-LEcta GmbH is one of the fastest growing biotech companies. Among c-LEcta’s customers are manufacturers of corona vaccines as well as the who’s who of global pharmaceutical and food companies. A real success story, to which SHS has also contributed its share. Now SHS has sold its shares in c-LEcta to the Irish Kerry Group, thus realising a highly successful exit.

Further information: Press release exit c-LEcta